You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure

 

Online download statistics by month:

Online download statistics by month: June 2016 to March 2024

AbstractFullPdf
Jun 2016154544175
Jul 20163942353
Aug 20161661533
Sep 20161101615
Oct 2016911217
Nov 20168526
Dec 201684020135
Jan 201755412169
Feb 20172014539
Mar 20171153323
Apr 20171201515
May 2017593618
Jun 20171061912
Jul 20171872211
Aug 2017167185
Sep 2017142158
Oct 20171961515
Nov 20171791716
Dec 20171781210
Jan 2018140910
Feb 201816668
Mar 201815764
Apr 201890126
May 201814075
Jun 201811821
Jul 201812445
Aug 201810773
Sep 2018141109
Oct 20181501512
Nov 201814641
Dec 201812251
Jan 20199533
Feb 201915644
Mar 201919595
Apr 201924221
May 201910440
Jun 20198731
Jul 2019101104
Aug 20197430
Sep 20198687
Oct 20197885
Nov 20198454
Dec 20196821
Jan 20207321
Feb 20207630
Mar 202016830
Apr 20204000
May 20207452
Jun 20204732
Jul 202013610
Aug 20205111
Sep 202011031
Oct 20208162
Nov 20206771
Dec 20206610
Jan 20215961
Feb 202110945
Mar 2021158141
Apr 20217420
May 20215030
Jun 2021110
Jul 2021533
Aug 20211061
Sep 20211273
Oct 202110651
Nov 202113720
Dec 202113462
Jan 20229640
Feb 202210121
Mar 202212564
Apr 202222050
May 202225231
Jun 202219093
Jul 202220081
Aug 202225151
Sep 202224442
Oct 202223061
Nov 202221840
Dec 202211320
Jan 202311931
Feb 202323130
Mar 202313600
Apr 20237622
May 202311921
Jun 20236130
Jul 20238011
Aug 202310121
Sep 20235400
Oct 20237600
Nov 202315022
Dec 202310752
Jan 20243614
Feb 20242000
Mar 20247022
Total13926717932